Justin David Gover's most recent trade in Design Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Design Therapeutics Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Xenon Pharma Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 10,507 | 10,507 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Justin David Gover | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 2,645 | 0 | - | - | Restricted Share Units | |
| Xenon Pharma Inc | Justin David Gover | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 2,645 | 2,645 (0%) | 0% | - | Common Shares | |
| Xenon Pharma Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 1,593 | 1,593 | - | - | Restricted Share Units | |
| Compass Pathways PLC (ADR) | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 21,110 | 21,110 | - | - | Share Option (Right to Buy) | |
| Design Therapeutics Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 45,000 | 45,000 | - | - | Stock option (right to buy) | |
| Design Therapeutics Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2025 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Design Therapeutics Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2025 | 15,833 | 15,833 | - | - | Stock option (right to buy) | |
| Compass Pathways PLC (ADR) | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 52,000 | 52,000 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 17,012 | 17,012 | - | - | Share Option (Right to Buy) | |
| Xenon Pharma Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 2,645 | 2,645 | - | - | Restricted Share Units | |
| Xenon Pharma Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 15,542 | 15,542 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharma Inc | Justin David Gover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) |